Merck & Co. (prior to spin-off)

URI: https://gptkb.org/entity/Merck_&_Co._(prior_to_spin-off)

GPTKB entity

Statements (50)

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:alsoKnownAs	gptkb:MSD_(outside_United_States_and_Canada)
gptkbp:businessModel	gptkb:Merck_&_Co.,_Inc.
gptkbp:country	gptkb:United_States
gptkbp:focusArea	gptkb:diabetes animal health infectious diseases oncology vaccines
gptkbp:founded	1891
gptkbp:founder	gptkb:George_Merck
gptkbp:headquartersLocation	gptkb:Kenilworth,_New_Jersey,_United_States
https://www.w3.org/2000/01/rdf-schema#label	Merck & Co. (prior to spin-off)
gptkbp:industry	healthcare pharmaceuticals
gptkbp:keyPerson	gptkb:Robert_M._Davis gptkb:Kenneth_C._Frazier
gptkbp:netIncome	$9.8 billion (2019)
gptkbp:notableAcquisition	gptkb:Millipore_(2010) gptkb:Cubist_Pharmaceuticals_(2015) gptkb:Schering-Plough_(2009)
gptkbp:notableEvent	Gardasil approval (2006) Keytruda approval (2014) Vioxx withdrawal (2004)
gptkbp:nowPartOf	gptkb:Merck_Group_(Germany)
gptkbp:numberOfEmployees	~74,000 (2019)
gptkbp:parentCompany	Merck Group (originally, until 1917)
gptkbp:product	gptkb:Simvastatin gptkb:Gardasil gptkb:Isentress gptkb:Januvia gptkb:Keytruda gptkb:Propecia gptkb:Singulair gptkb:Zetia
gptkbp:publiclyTraded	yes
gptkbp:revenue	$46.8 billion (2019)
gptkbp:servesArea	worldwide
gptkbp:spinOff	June 2021 Organon & Co.
gptkbp:stockExchange	gptkb:Dow_Jones_Industrial_Average gptkb:S&P_500 gptkb:S&P_100
gptkbp:stockSymbol	gptkb:MRK
gptkbp:subsidiary	gptkb:Merck_Research_Laboratories gptkb:MSD_Animal_Health
gptkbp:tradedOn	NYSE: MRK
gptkbp:website	https://www.merck.com/
gptkbp:bfsParent	gptkb:Organon_(2021_spin-off)
gptkbp:bfsLayer	6